Ignite Creation Date:
2025-12-25 @ 5:07 AM
Ignite Modification Date:
2026-03-06 @ 2:52 AM
Study NCT ID:
NCT00049127
Status:
COMPLETED
Last Update Posted:
2019-10-21
First Post:
2002-11-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Sponsor:
Alliance for Clinical Trials in Oncology
Organization: